WO2009112022A3 - Pharmazeutische zusammensetzung zur diagnose oder behandlung von zinkfinger protein assoziierten erkrankungen - Google Patents

Pharmazeutische zusammensetzung zur diagnose oder behandlung von zinkfinger protein assoziierten erkrankungen Download PDF

Info

Publication number
WO2009112022A3
WO2009112022A3 PCT/DE2009/000337 DE2009000337W WO2009112022A3 WO 2009112022 A3 WO2009112022 A3 WO 2009112022A3 DE 2009000337 W DE2009000337 W DE 2009000337W WO 2009112022 A3 WO2009112022 A3 WO 2009112022A3
Authority
WO
WIPO (PCT)
Prior art keywords
zinc finger
diagnosis
treatment
finger proteins
pharmaceutical composition
Prior art date
Application number
PCT/DE2009/000337
Other languages
English (en)
French (fr)
Other versions
WO2009112022A2 (de
Inventor
Volker A. Erdmann
Original Assignee
Freie Universität Berlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Freie Universität Berlin filed Critical Freie Universität Berlin
Publication of WO2009112022A2 publication Critical patent/WO2009112022A2/de
Publication of WO2009112022A3 publication Critical patent/WO2009112022A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Die Erfindung betrifft Nukleinsäuren, welche an Zinkfinger Proteine, beispielsweise das humane ZFY- Protein oder an das humane Glioblastom Oncogen Protein, binden, und deren Verwendungen.
PCT/DE2009/000337 2008-03-10 2009-03-10 Pharmazeutische zusammensetzung zur diagnose oder behandlung von zinkfinger protein assoziierten erkrankungen WO2009112022A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008013623.9 2008-03-10
DE102008013623A DE102008013623A1 (de) 2008-03-10 2008-03-10 Pharmazeutische Zusammensetzung zur Diagnose oder Behandlung von Zinkfinger Protein assoziierten Erkrankungen

Publications (2)

Publication Number Publication Date
WO2009112022A2 WO2009112022A2 (de) 2009-09-17
WO2009112022A3 true WO2009112022A3 (de) 2010-04-22

Family

ID=40983825

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2009/000337 WO2009112022A2 (de) 2008-03-10 2009-03-10 Pharmazeutische zusammensetzung zur diagnose oder behandlung von zinkfinger protein assoziierten erkrankungen

Country Status (2)

Country Link
DE (1) DE102008013623A1 (de)
WO (1) WO2009112022A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112188892A (zh) * 2018-03-20 2021-01-05 阿布拉科斯生物科学有限公司 通过mTOR抑制剂和白蛋白的纳米颗粒的施用治疗中枢神经系统障碍的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000028088A1 (en) * 1998-11-10 2000-05-18 Biocrystal Limited Nanocrystals having polynucleotide strands and their use to form dendrimers in a signal amplification system
WO2004027381A2 (en) * 2002-09-17 2004-04-01 University Of Utah Research Foundation Methods and compositions related to inhibiting nuclear envelope breakdown
WO2008137595A1 (en) * 2007-05-01 2008-11-13 University Of Miami A transcriptomic biomarker of myocarditis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9710809D0 (en) * 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
US6949379B2 (en) * 2000-10-20 2005-09-27 Canji, Inc. Aptamer-mediated regulation of gene expression

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000028088A1 (en) * 1998-11-10 2000-05-18 Biocrystal Limited Nanocrystals having polynucleotide strands and their use to form dendrimers in a signal amplification system
WO2004027381A2 (en) * 2002-09-17 2004-04-01 University Of Utah Research Foundation Methods and compositions related to inhibiting nuclear envelope breakdown
WO2008137595A1 (en) * 2007-05-01 2008-11-13 University Of Miami A transcriptomic biomarker of myocarditis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHAI GARY ET AL: "Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1", BIOCHEMISTRY, vol. 40, no. 7, 20 February 2001 (2001-02-20), pages 2032 - 2040, XP002567633, ISSN: 0006-2960 *

Also Published As

Publication number Publication date
DE102008013623A1 (de) 2009-09-24
WO2009112022A2 (de) 2009-09-17

Similar Documents

Publication Publication Date Title
UA113609C2 (xx) Антигензв'язуючий білок, який зв'язує людський il-23
WO2012083302A3 (en) Compositions and methods for the treatment or prevention of human adenovirus-36 infection
WO2008101985A3 (en) Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization
WO2011060206A3 (en) Material and methods for treating or preventing her-3 associated diseases
WO2010010551A3 (en) Angiopoietin derived peptides
EP2915818A3 (de) Immunglobuline mit zweifacher variabler domäne und verwendungen davon
WO2011028811A3 (en) Dual variable domain immunoglobulins and uses thereof
IL210485A (en) An isolated antibody or its functional protein, a process for making it, a pharmaceutical preparation containing it, and an isolated amino acid encoding an antibody or a functional protein
WO2009147248A3 (en) Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
WO2011059755A3 (en) Dual variable domain immunoglobulins and uses thereof
WO2011050262A3 (en) Dual variable domain immunoglobulins and uses thereof
WO2011047262A3 (en) Dual variable domain immunoglobulins and uses thereof
WO2011014659A3 (en) Dual variable domain immunoglobulins and uses thereof
WO2010127284A3 (en) Dual variable domain immunoglobulins and uses thereof
EP2987807A3 (de) Antikörper gegen phosphoryliertes tau
MX2022013520A (es) Polipeptidos que se enlazan a cxcr2.
WO2009070294A3 (en) Inhibition of macrophage-stimulating protein receptor (ron) and methods of treatment thereof
EP2826791A3 (de) Humanisierte anti-C5aR- Antikörper
WO2011036445A3 (en) Polypeptides and uses thereof
WO2007111661A3 (en) Human antibodies specific for gastrin materials and methods
WO2012007839A3 (en) Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
WO2008076954A3 (en) Heterocycle compounds and methods of use thereof
WO2010072740A3 (en) TARGETED BINDING AGENTS DIRECTED TO α5β1 AND USES THEREOF
WO2009047513A3 (en) Antagonists of kisspeptin and uses thereof
WO2009138494A3 (en) Amino acid sequences directed against toll-like receptors and their use for the treatment of diseases related to toll-like receptors

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09720725

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 09720725

Country of ref document: EP

Kind code of ref document: A2